Kristie Xian is an associate with Jones Day based in the firm’s Washington, D.C. office. Her practice focuses on all aspects of antitrust matters, including merger review, litigation, compliance counseling, and government investigations. She has successfully guided multiple clients involved in investigations by the U.S. Department of Justice, Federal Trade Commission, and state antitrust authorities. Kristie has extensive experience in representing clients in a broad range of industries, including health care, industrial applications, medical devices, chemicals, technology, and consumer products. She has helped companies effectively respond to a range of antitrust issues, from premerger planning, conduct investigations, regulatory filings under the Hart-Scott-Rodino Act, federal and state investigations, and federal antitrust litigation, including defeating the government’s motion seeking a preliminary injunction in the merger of Penn State Hershey Medical Center and the PinnacleHealth System. Kristie also maintains an active pro bono practice. She was recognized by the Domestic Violence Legal Empowerment and Appeals Project as part of the Pro Bono Team of the Year for her work on a child custody appeal.
146
In Short The Situation : Overruling its precedent, the United States Court of Appeals for the Seventh Circuit held that the Federal Trade Commission ("FTC") may not seek restitution under FTC Act Section 13(b) because the statute, which permits the FTC to obtain injunctions, does not (...)
46
In a decision that extends the FTC’s winning streak in the courts of appeals in healthcare provider merger cases, the Eighth Circuit affirmed the Federal Trade Commission’s ("FTC") bid to enjoin Sanford Health’s acquisition of Mid Dakota Clinic ("MDC"). This decision follows almost three years (...)
25
In Short The Development : A Federal Trade Commission ("FTC") administrative judge ("ALJ") has blocked Tronox Corporation’s proposed acquisition of the titanium dioxide ("TiO2") business of The National Titanium Dioxide Company Limited ("Cristal"), concluding that the transaction may (...)
